Health Plans Anticipate 14% Premium Hikes for 2027 Amid Rising Costs
August 15, 2026
Driven by inflation and the high cost of GLP-1 drugs, health insurers are projecting median premium increases of 14% heading into 2027.
Driven by inflation and the high cost of GLP-1 drugs, health insurers are projecting median premium increases of 14% heading into 2027.
Medicare has named 15 additional prescription drugs for price negotiations, building on the Inflation Reduction Act’s cost-cutting momentum.
Medicare Part D now caps annual out-of-pocket drug costs at $2,000. Here’s how the cap works and how the payment plan can help you save.